CRSP Archives - Spark Newswire

2 minute read

CRISPR Therapeutics Announces Leadership Transition; Co-Founder, Rodger Novak, M.D., To Step Down As President And Chairman; CEO Samarth Kulkarni, Ph.D., To Succeed Dr. Novak As Chairman Effective September 15, 2023

September 7, 8:35 AM

-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September 15, 2023- -Samarth Kulkarni, Ph.D., to succeed Dr. Novak as Chairman and will continue serving as CEO of

CRSP

2 minute read

Uncategorized

Cathie Wood’s Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge

By Benzinga Neuro

August 24, 10:57 PM

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling $1.86 million worth of shares in…

ACCD

2 minute read

Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M

By Benzinga Neuro

August 22, 9:50 PM

Cathie Wood-led Ark Invest made significant trades on Tuesday, including a noteworthy move involving Zoom Video Communications (NASDAQ:ZM)…

ADPT

2 minute read

Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company’s Stock Instead

By Benzinga Neuro

August 21, 10:27 PM

On Monday, August 21, 2023, Cathie Wood-led Ark Invest made significant moves in the market, with a notable…

ADPT

1 minute read

Analyst Ratings

What 13 Analyst Ratings Have To Say About CRISPR Therapeutics

By Benzinga Insights

August 14, 11:00 AM

CRISPR Therapeutics (NASDAQ:CRSP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

CRSP

2 minute read

Cathie Wood Buys Roblox, Palantir Dips — Ark Invest Seizes Buying Opportunities Following Earnings Reports

By Benzinga Neuro

August 9, 11:11 PM

On Wednesday, Cathie Wood-led Ark Invest made a significant move by purchasing shares of Roblox Corp (NYSE:RBLX) following…

ARKF

2 minute read

Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors’ Focus On Non-CF Pipeline

By Vandana Singh

August 2, 2:10 PM

Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill

CRSP

2 minute read

Analyst Ratings

The Latest Analyst Ratings for CRISPR Therapeutics

By Benzinga Insights

July 25, 9:00 AM

Over the past 3 months, 13 analysts have published their opinion on CRISPR Therapeutics (NASDAQ:CRSP) stock. These analysts…

CRSP

2 minute read

Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here’s How Much Shares Ark Offloaded Monday

By Shanthi Rexaline

July 3, 10:27 PM

Tesla. Inc. (NASDAQ:TSLA) rallied over 6% in Monday’s truncated session as traders bid up the stock following its…

ARKK

1 minute read

Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics’ Exa-cel Application

By Vandana Singh

June 9, 2:08 PM

The FDA has accepted the application for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG (NASDAQ: CRSP) exa-cel for sickle cell disease and transfusion-dependent

BLUE

Feed Symbols: CRSP